Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.76
TNDM's Cash to Debt is ranked lower than
68% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. TNDM: 0.76 )
Ranked among companies with meaningful Cash to Debt only.
TNDM' s Cash to Debt Range Over the Past 10 Years
Min: 0.53  Med: 2.99 Max: N/A
Current: 0.76
Equity to Asset 0.06
TNDM's Equity to Asset is ranked lower than
93% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. TNDM: 0.06 )
Ranked among companies with meaningful Equity to Asset only.
TNDM' s Equity to Asset Range Over the Past 10 Years
Min: -2.66  Med: 0.51 Max: 0.71
Current: 0.06
-2.66
0.71
F-Score: 4
Z-Score: -6.87
M-Score: -3.80
WACC vs ROIC
7.29%
-377.40%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -89.90
TNDM's Operating margin (%) is ranked lower than
77% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. TNDM: -89.90 )
Ranked among companies with meaningful Operating margin (%) only.
TNDM' s Operating margin (%) Range Over the Past 10 Years
Min: -1335.27  Med: -161.3 Max: -89.9
Current: -89.9
-1335.27
-89.9
Net-margin (%) -95.57
TNDM's Net-margin (%) is ranked lower than
77% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 2.25 vs. TNDM: -95.57 )
Ranked among companies with meaningful Net-margin (%) only.
TNDM' s Net-margin (%) Range Over the Past 10 Years
Min: -1333.94  Med: -188.81 Max: -95.57
Current: -95.57
-1333.94
-95.57
ROE (%) -185.19
TNDM's ROE (%) is ranked lower than
93% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. TNDM: -185.19 )
Ranked among companies with meaningful ROE (%) only.
TNDM' s ROE (%) Range Over the Past 10 Years
Min: -1331.34  Med: -122.7 Max: -93.5
Current: -185.19
-1331.34
-93.5
ROA (%) -70.33
TNDM's ROA (%) is ranked lower than
84% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.44 vs. TNDM: -70.33 )
Ranked among companies with meaningful ROA (%) only.
TNDM' s ROA (%) Range Over the Past 10 Years
Min: -182.5  Med: -62.54 Max: -59.2
Current: -70.33
-182.5
-59.2
ROC (Joel Greenblatt) (%) -322.76
TNDM's ROC (Joel Greenblatt) (%) is ranked lower than
77% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 4.32 vs. TNDM: -322.76 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
TNDM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -598.61  Med: -463.37 Max: -320.57
Current: -322.76
-598.61
-320.57
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» TNDM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

TNDM Guru Trades in Q4 2015

Jim Simons 164,300 sh (+18.35%)
Steven Cohen 796,756 sh (-29.52%)
» More
Q1 2016

TNDM Guru Trades in Q1 2016

Jim Simons 239,300 sh (+45.65%)
Steven Cohen 825,000 sh (+3.54%)
John Paulson 540,000 sh (unchged)
» More
Q2 2016

TNDM Guru Trades in Q2 2016

Jim Simons 294,300 sh (+22.98%)
Steven Cohen 850,000 sh (+3.03%)
» More
Q3 2016

TNDM Guru Trades in Q3 2016

Jim Simons 356,400 sh (+21.10%)
Steven Cohen 983,514 sh (+15.71%)
» More
» Details

Insider Trades

Latest Guru Trades with TNDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NAS:PAVM, NAS:EYES, NAS:SRTS, NAS:NVTR, AMEX:CVRS, OTCPK:ARTH, NAS:AVGR, NAS:SPNE, OTCPK:AVMXF, NAS:SPAN, NAS:VIVE, OTCPK:LCTC, NAS:DRAD, OTCPK:BLOZF, OTCPK:QTVLF, NAS:EDAP, OTCPK:BTCY, OTCPK:DIZTF, NAS:RWLK, OTCPK:TITXF » details
Traded in other countries:TD5.Germany,
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company's flagship product is the t:slim Insulin Delivery System.

Ratios

vs
industry
vs
history
P/B 14.67
TNDM's P/B is ranked lower than
94% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. TNDM: 14.67 )
Ranked among companies with meaningful P/B only.
TNDM' s P/B Range Over the Past 10 Years
Min: 3.23  Med: 4.92 Max: 49.47
Current: 14.67
3.23
49.47
P/S 0.87
TNDM's P/S is ranked higher than
83% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. TNDM: 0.87 )
Ranked among companies with meaningful P/S only.
TNDM' s P/S Range Over the Past 10 Years
Min: 0.22  Med: 2.82 Max: 6.32
Current: 0.87
0.22
6.32
Current Ratio 2.04
TNDM's Current Ratio is ranked lower than
62% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. TNDM: 2.04 )
Ranked among companies with meaningful Current Ratio only.
TNDM' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.97 Max: 10.21
Current: 2.04
1.63
10.21
Quick Ratio 1.38
TNDM's Quick Ratio is ranked lower than
64% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. TNDM: 1.38 )
Ranked among companies with meaningful Quick Ratio only.
TNDM' s Quick Ratio Range Over the Past 10 Years
Min: 1.26  Med: 4.18 Max: 9.5
Current: 1.38
1.26
9.5
Days Inventory 126.87
TNDM's Days Inventory is ranked higher than
51% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 131.45 vs. TNDM: 126.87 )
Ranked among companies with meaningful Days Inventory only.
TNDM' s Days Inventory Range Over the Past 10 Years
Min: 116.18  Med: 125.16 Max: 298.88
Current: 126.87
116.18
298.88
Days Sales Outstanding 35.43
TNDM's Days Sales Outstanding is ranked higher than
89% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 67.65 vs. TNDM: 35.43 )
Ranked among companies with meaningful Days Sales Outstanding only.
TNDM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.43  Med: 68.55 Max: 355.71
Current: 35.43
35.43
355.71
Days Payable 35.61
TNDM's Days Payable is ranked lower than
72% of the 253 Companies
in the Global Medical Devices industry.

( Industry Median: 56.36 vs. TNDM: 35.61 )
Ranked among companies with meaningful Days Payable only.
TNDM' s Days Payable Range Over the Past 10 Years
Min: 20.64  Med: 39.44 Max: 161.64
Current: 35.61
20.64
161.64

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 24.09
TNDM's Price/Tangible Book is ranked lower than
91% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. TNDM: 24.09 )
Ranked among companies with meaningful Price/Tangible Book only.
TNDM' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.76  Med: 5.3 Max: 70.28
Current: 24.09
3.76
70.28
Price/Median PS Value 0.33
TNDM's Price/Median PS Value is ranked higher than
91% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. TNDM: 0.33 )
Ranked among companies with meaningful Price/Median PS Value only.
TNDM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.1  Med: 1.06 Max: 2.1
Current: 0.33
0.1
2.1
Earnings Yield (Greenblatt) (%) -86.65
TNDM's Earnings Yield (Greenblatt) (%) is ranked lower than
94% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. TNDM: -86.65 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
TNDM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -94.97  Med: 220 Max: 491.7
Current: -86.65
-94.97
491.7

More Statistics

Revenue (TTM) (Mil) $84.46
EPS (TTM) $ -2.63
Beta0.37
Short Percentage of Float9.10%
52-Week Range $1.60 - 11.30
Shares Outstanding (Mil)30.64

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 88 110 151 194
EPS ($) -2.70 -2.27 -1.15 -0.52
EPS w/o NRI ($) -2.70 -2.27 -1.15 -0.52
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for TNDM

Headlines

Articles On GuruFocus.com

More From Other Websites
Biotech Industry Outperforming Markets in 2017: Latest Reports on Benitec Biopharma and Tandem... Jan 18 2017
DexCom Jumps 25% As It Becomes Only Continuous Glucose Monitoring With Medicare Coverage Jan 13 2017
ETFs with exposure to Tandem Diabetes Care, Inc. : January 9, 2017 Jan 09 2017
ETFs with exposure to Tandem Diabetes Care, Inc. : December 19, 2016 Dec 19 2016
Here is What Hedge Funds Think About Tandem Diabetes Care Inc (TNDM) Dec 12 2016
ETFs with exposure to Tandem Diabetes Care, Inc. : December 9, 2016 Dec 09 2016
Tandem Diabetes Care to Draw Down $35 Million under Existing Term Loan Facility with CRG Dec 01 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 29 2016
Tandem Diabetes Care to Draw Down $35 Million under Existing Term Loan Facility with CRG Nov 29 2016
Tandem Diabetes Care to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 21 2016
ETFs with exposure to Tandem Diabetes Care, Inc. : November 14, 2016 Nov 14 2016
NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem... Nov 12 2016
These 5 Stocks Under $10 Could Make You a Lot of Money Nov 11 2016
NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem... Nov 10 2016
Tandem Diabetes Care Reports Third Quarter 2016 Financial Results Nov 07 2016
TANDEM DIABETES CARE INC Financials Nov 05 2016
ETF’s with exposure to Tandem Diabetes Care, Inc. : November 4, 2016 Nov 04 2016
Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016 Nov 03 2016
Tandem Diabetes Care downgraded by Piper Jaffray Nov 03 2016
TANDEM DIABETES CARE INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)